Tuesday, September 28, 2021

Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia

New research shows why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and demonstrates a way to restore their effectiveness.

from Top Health News -- ScienceDaily https://ift.tt/3CRiklD
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Natural hormone unlocks a hidden fat burning switch

FGF19 triggers the brain to burn more energy and activate fat-burning cells, offering a potential new path for obesity treatments. The hormo...